<DOC>
	<DOC>NCT00914693</DOC>
	<brief_summary>The aim of the present study is to prove efficacy and safety of a new contraceptive patch.</brief_summary>
	<brief_title>EU/LA Pearl Index Study - Transdermal Contraceptive Patch</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Gestodene</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Femovan</mesh_term>
	<criteria>Requiring contraception Normal cervical smear Smokers not older than 30 years History of regular cyclic menstrual periods Pregnancy or lactation Obesity (BMI&gt; 30 kg/m2 Significant skin reaction to transdermal preparations or sensitivity to surgical / medical tape Any disease that may worsen under hormonal treatment (cardiovascular, liver, metabolic) Use of other contraceptive methods than study medication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Fertility control</keyword>
	<keyword>Contraception</keyword>
</DOC>